Wednesday 18th May 2016 |
Text too small? |
Trilogy International, the skincare and home fragrance company, says it continues to comply with its market obligations after being asked to explain a 50 cent rise in its share price in four days of trading.
The value of shares in Trilogy has risen from a market low of $3.50 on May 13 to a high of $4.00 at 13:26 on May 18, an increase of 14.3%. That sparked a letter from the NZX asking whether the company is continuing to comply with the rules requiring the disclosure of information material to the share price.
In a response, Trilogy's Chief Financial Officer Lindsay Render said that the company "continues to comply with its continuous disclosure obligations".
Trilogy bought the New Zealand cosmetics and fragrance distribution business, CS Company, last August. In March it said that sales for the full-year to the end of March were expected to exceed $83 million, with profit before tax above $13 million, ahead of analysts expectations.
The company sells through the Trilogy, Ecoya and Goodness brands.
The shares have more than quadrupled in value since July 2015 when they traded at 91 cents. A short while ago they were trading at $3.95.
BusinessDesk.co.nz
No comments yet
MPG - Metroglass clarifies media statements by Crescent Capital
VTL - Takeovers Panel orders Empire to reimburse Vital's expenses
March 14th Morning Report
SKT - Sky secures iconic sports rights
RYM - Ryman completes Retail Entitlement Offer
TEM - Transaction in Own Shares
FPH launches F&P Nova™ Nasal mask in NZ and AU
Fonterra announces changes to management team
March 12th Morning Report
WHS FY25 Interim Results teleconference details